Dashenlin Pharma's Q1 Profit Rises 11%
Dashenlin Pharmaceutical Group's (SHA:603233) net profit attributable to shareholders in the first quarter rose 11% to 511.1 million yuan from the year-ago attributable profit of almost 460 million yuan, according to a Shanghai bourse filing on Friday.Earnings per share climbed 13% year on year to 0.45 yuan from 0.40 yuan.Operating revenue increased 0.3% to 6.97 billion yuan from 6.96 billion yuan in the previous year.The pharmaceutical company's shares rose 1% at the close.